Gujarat Themis Biosyn Annual General Meeting
Gujarat Themis Biosyn Limited has issued a Postal Ballot notice to approve increasing its borrowing and investment limits to ₹3,500 Crore each. These limits will support strategic initiatives, including a proposed acquisition of anti-tuberculosis brands from Sanofi. Remote e-voting commences on 6th May 2026 and concludes on 4th June 2026.
- Value
- ₹3,500 Cr